Operator of a novel cultivated-protein production process designed to create animal-cell-derived meat without conventional livestock. The company offers an RNA-based reprogramming technology along wit...

Healthcare
Cambridge, United Kingdom
Founded 2017
11 employees
Website
Valuation
$98.4M
Market implied
Share Price
N/A
Total Raised
$49.2M
Last Round
N/A

Get the full picture

Create a free account to unlock SymphoRNA's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required